Table 3.
Weekly evolution of salivary IgA and IL-6 concentrations and plasma cortisol concentration for SL and CON groups from pre to post phase II
| Pre | Phase II | Post | |||
|---|---|---|---|---|---|
| Week 1 | Week 2 | Week 3 | |||
| sIgA (µg/mL) | |||||
| SL | 353.7 ± 188.7 | 319.1 ± 167.5 | 286.7 ± 154.5 | 297.4 ± 132.5 | 241.6 ± 98.1* |
| CON | 390.6 ± 235.0 | 270.5 ± 139.7 | 359.2 ± 148.4 | 382.6 ± 168.5 | 348.3 ± 153.9 |
| sIL-6 (pg/mL) | |||||
| SL | 2.6 ± 0.3 | 2.6 ± 0.4 | 2.7 ± 0.4 | 2.6 ± 0.4 | 2.6 ± 0.5 |
| CON | 2.8 ± 0.3 | 2.8 ± 0.2 | 2.6 ± 0.4 | 2.7 ± 0.4 | 2.7 ± 0.5 |
| Cortisol (µg/L) | |||||
| SL | 157.2 ± 40.2 | 140.4 ± 34.9 | 159.3 ± 26.2 | 155.6 ± 28.8 | 148.0 ± 34.0 |
| CON | 177.1 ± 30.1 | 180.6 ± 38.9 | 169.9 ± 39.3 | 176.2 ± 36.7 | 155.7 ± 33.7 |
Data are mean ± SD
* Significantly different from values recorded in pre (P < 0.05)